These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 23674848)
1. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors. Liu LC; Xu WT; Wu X; Zhao P; Lv YL; Chen L World J Gastroenterol; 2013 Apr; 19(16):2473-80. PubMed ID: 23674848 [TBL] [Abstract][Full Text] [Related]
2. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors. Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631 [TBL] [Abstract][Full Text] [Related]
3. CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis. Lu C; Liu L; Wu X; Xu W Oncol Lett; 2013 Nov; 6(5):1289-1294. PubMed ID: 24179510 [TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors. Wang Y; Chen JJ; Wang XF; Wang Q World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE; Kim MA; Lee HS; Lee BL; Kim WH J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway. Steigen SE; Bjerkehagen B; Haugland HK; Nordrum IS; Løberg EM; Isaksen V; Eide TJ; Nielsen TO Mod Pathol; 2008 Jan; 21(1):46-53. PubMed ID: 17917670 [TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population. Li J; Zhang H; Chen Z; Su K Int J Clin Exp Pathol; 2015; 8(12):15969-76. PubMed ID: 26884871 [TBL] [Abstract][Full Text] [Related]
9. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036 [TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor]. Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic Gastrointestinal Stromal Tumor: Clinicopathologic Features and Prognosis. Liu Z; Tian Y; Xu G; Liu S; Guo M; Lian X; Fan D; Zhang H; Feng F J Clin Gastroenterol; 2017 Oct; 51(9):850-856. PubMed ID: 27673752 [TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients. Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047 [TBL] [Abstract][Full Text] [Related]
14. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China. Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z; Cancer Med; 2017 Dec; 6(12):2796-2803. PubMed ID: 29058376 [TBL] [Abstract][Full Text] [Related]
15. Retrospective study of the clinicopathological characteristics and prognostic factors of gastrointestinal stromal tumors in Chinese patients. Hu X; Zhang Q; Wang Z; Ren H; Su P; Kou Y Ann Diagn Pathol; 2022 Dec; 61():152050. PubMed ID: 36257237 [TBL] [Abstract][Full Text] [Related]
16. Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival. Xu SJ; Zhang SY; Dong LY; Lin GS; Zhou YJ BMC Cancer; 2021 Nov; 21(1):1170. PubMed ID: 34724907 [TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization. Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables. Unalp HR; Derici H; Kamer E; Bozdag AD; Tarcan E; Onal MA Can J Surg; 2009 Feb; 52(1):31-8. PubMed ID: 19234649 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers? Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035 [TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hasegawa T; Matsuno Y; Shimoda T; Hirohashi S Hum Pathol; 2002 Jun; 33(6):669-76. PubMed ID: 12152168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]